Search

Arye Lipman Phones & Addresses

  • 1502 Broadway UNIT 308, Santa Monica, CA 90404
  • Culver City, CA
  • Marina del Rey, CA
  • Carmel, CA
  • Big Sur, CA

Work

Company: Imaginab Feb 2011 Position: Director of business development, pre-clinical pharma collaborations

Education

Degree: B.S. School / High School: University of California, Los Angeles 2004 to 2008 Specialities: Molecular Biology, French

Skills

Molecular Biology • Biotechnology • Cancer • Life Sciences • Genomics • Cell Culture • Lifesciences • Management • Antibodies • Business Development • Assay Development • Cell Biology • Oncology • Business Strategy • Biochemistry • Cell • Research • Commercialization • Clinical Trials • Purification • Translational Research • Drug Discovery • Strategic Partnerships • Pcr • Cancer Research • Immunology • Sales • Finance • Protein Chemistry • Laboratory • Strategy • Program Management • Marketing • Partnering • Process Improvement • Scientific Writing • Healthcare • Pharmaceutical Industry • Hplc • Molecular Imaging • Protein Engineering • Genetics • Biopharmaceuticals

Languages

English • French • Spanish

Ranks

Certificate: Radiation Handling

Interests

Molecular Biology • Water Sports • Social Services • Economic Empowerment • Civil Rights and Social Action • Health • Surrealist Art • Education • Jazz • Literature • Psychopharmacology • Protein Engineering • Science and Technology • Muralism • Human Rights • Arts and Culture • Genomics

Industries

Biotechnology

Resumes

Resumes

Arye Lipman Photo 1

General Partner

View page
Location:
4179 Ince Blvd, Culver City, CA 90232
Industry:
Biotechnology
Work:
ImaginAb since Feb 2011
Director of Business Development, Pre-clinical Pharma Collaborations

California Science Center Dec 2009 - Dec 2011
Volunteer

ImaginAb Aug 2008 - Feb 2011
Scientist

UCLA Medical Center Sep 2006 - Jun 2008
Researcher at Jonsson Comprehensive Cancer Center

UCLA Medical Center Jan 2005 - Jun 2008
Researcher in Pathology and Lab Medicine
Education:
University of California, Los Angeles 2004 - 2008
B.S., Molecular Biology, French
National University of Singapore 2006 - 2007
FANFE
Skills:
Molecular Biology
Biotechnology
Cancer
Life Sciences
Genomics
Cell Culture
Lifesciences
Management
Antibodies
Business Development
Assay Development
Cell Biology
Oncology
Business Strategy
Biochemistry
Cell
Research
Commercialization
Clinical Trials
Purification
Translational Research
Drug Discovery
Strategic Partnerships
Pcr
Cancer Research
Immunology
Sales
Finance
Protein Chemistry
Laboratory
Strategy
Program Management
Marketing
Partnering
Process Improvement
Scientific Writing
Healthcare
Pharmaceutical Industry
Hplc
Molecular Imaging
Protein Engineering
Genetics
Biopharmaceuticals
Interests:
Molecular Biology
Water Sports
Social Services
Economic Empowerment
Civil Rights and Social Action
Health
Surrealist Art
Education
Jazz
Literature
Psychopharmacology
Protein Engineering
Science and Technology
Muralism
Human Rights
Arts and Culture
Genomics
Languages:
English
French
Spanish
Certifications:
Radiation Handling
Advanced Scuba Diver
Laser Safety
Ucla Radiation Safety Program
Ucla Eh&S
Ssi

Publications

Us Patents

J591 Minibodies And Cys-Diabodies For Targeting Human Prostate Specific Membrane Antigen (Psma) And Methods For Their Use

View page
US Patent:
20110268656, Nov 3, 2011
Filed:
Dec 2, 2010
Appl. No.:
12/959340
Inventors:
David Ho - Los Angeles CA, US
Tove Olafsen - Reseda CA, US
Arye Lipman - El Segundo CA, US
International Classification:
A61K 51/10
A61P 37/02
A61K 39/395
A61P 35/00
C07K 16/32
A61K 49/00
US Classification:
424 149, 5303873, 424 91, 4241331, 4241781
Abstract:
In one embodiment, a minibody monomer that binds PSMA is provided. The minibody monomer is encoded by a nucleotide sequence comprising, from N-terminus to C-terminus, an scFv sequence that can bind PSMA, an artificial hinge sequence, and a human IgG CH3 sequence. In another embodiment, a CysDB monomer that binds PSMA is provided. The CysDB monomer may be encoded by a nucleotide sequence comprising, from N-terminus to C-terminus, an scFv sequence that can bind PSMA and a cysteine tail. In other embodiments, methods for diagnosing or treating a cancer associated with PSMA expression in a subject are provided.

J591 Minibodies And Cys-Diabodies For Targeting Human Prostate Specific Membrane Antigen (Psma) And Methods For Their Use

View page
US Patent:
20190300622, Oct 3, 2019
Filed:
Feb 12, 2019
Appl. No.:
16/273948
Inventors:
- Inglewood CA, US
Tove Olafsen - Reseda CA, US
Arye Lipman - El Segundo CA, US
International Classification:
C07K 16/30
A61P 35/00
A61K 51/10
Abstract:
In one embodiment, a minibody monomer that binds PSMA is provided. The minibody monomer is encoded by a nucleotide sequence comprising, from N-terminus to C-terminus, an scFv sequence that can bind PSMA, an artificial hinge sequence, and a human IgG CH3 sequence. In another embodiment, a CysDB monomer that binds PSMA is provided. The CysDB monomer may be encoded by a nucleotide sequence comprising, from N-terminus to C-terminus, an scFv sequence that can bind PSMA and a cysteine tail. In other embodiments, methods for diagnosing or treating a cancer associated with PSMA expression in a subject are provided.

J591 Minibodies And Cys-Diabodies For Targeting Human Prostate Specific Membrane Antigen (Psma) And Methods For Their Use

View page
US Patent:
20140234215, Aug 21, 2014
Filed:
Apr 30, 2014
Appl. No.:
14/266391
Inventors:
- Inglewood CA, US
Tove Olafsen - Reseda CA, US
Arye Lipman - El Segundo CA, US
Assignee:
ImaginAb, Inc. - Inglewood CA
International Classification:
C07K 16/30
US Classification:
424 149, 5303873, 4241351, 4241781
Abstract:
In one embodiment, a minibody monomer that binds PSMA is provided. The minibody monomer is encoded by a nucleotide sequence comprising, from N-terminus to C-terminus, an scFv sequence that can bind PSMA, an artificial hinge sequence, and a human IgG CH3 sequence. In another embodiment, a CysDB monomer that binds PSMA is provided. The CysDB monomer may be encoded by a nucleotide sequence comprising, from N-terminus to C-terminus, an scFv sequence that can bind PSMA and a cysteine tail. In other embodiments, methods for diagnosing or treating a cancer associated with PSMA expression in a subject are provided.
Arye A Lipman from Santa Monica, CA, age ~38 Get Report